000			01922 a2200541 4500
005			20250516214658.0
264		0	_c20150428
008			201504s 0 0 eng d
022			_a1472-6882
024	7		_a10.1186/1472-6882-14-159 _2doi
040			_aNLM _beng _cNLM
100	1		_aHenrotin, Yves
245	0	0	_aDecrease of a specific biomarker of collagen degradation in osteoarthritis, Coll2-1, by treatment with highly bioavailable curcumin during an exploratory clinical trial. _h[electronic resource]
260			_bBMC complementary and alternative medicine _cMay 2014
300			_a159 p. _bdigital
500			_aPublication Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAnti-Inflammatory Agents _xtherapeutic use
650	0	4	_aAnti-Inflammatory Agents, Non-Steroidal _xtherapeutic use
650	0	4	_aBiomarkers _xblood
650	0	4	_aC-Reactive Protein _xmetabolism
650	0	4	_aCollagen _xblood
650	0	4	_aCollagen Type I _xurine
650	0	4	_aCurcumin _xtherapeutic use
650	0	4	_aExtracellular Matrix Proteins _xblood
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aOsteoarthritis _xdrug therapy
650	0	4	_aOsteoarthritis, Knee _xdrug therapy
650	0	4	_aPain Measurement
650	0	4	_aPeptides _xurine
650	0	4	_aPeroxidase _xblood
650	0	4	_aPhytotherapy
650	0	4	_aTreatment Outcome
700	1		_aGharbi, Myriam
700	1		_aDierckxsens, Yvan
700	1		_aPriem, Fabian
700	1		_aMarty, Marc
700	1		_aSeidel, Laurence
700	1		_aAlbert, Adelin
700	1		_aHeuse, Elisabeth
700	1		_aBonnet, Valérie
700	1		_aCastermans, Caroline
773	0		_tBMC complementary and alternative medicine _gvol. 14 _gp. 159
856	4	0	_uhttps://doi.org/10.1186/1472-6882-14-159 _zAvailable from publisher's website
999			_c23878012 _d23878012